nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCB1—ovarian cancer	0.0989	1	CbGaD
Cyclosporine—SLCO1A2—Chlorambucil—ovarian cancer	0.0551	0.0992	CbGbCtD
Cyclosporine—ABCC10—Paclitaxel—ovarian cancer	0.0548	0.0987	CbGbCtD
Cyclosporine—ABCC10—Docetaxel—ovarian cancer	0.0396	0.0714	CbGbCtD
Cyclosporine—ABCB11—Paclitaxel—ovarian cancer	0.0298	0.0537	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—ovarian cancer	0.0295	0.0532	CbGbCtD
Cyclosporine—ABCG2—Topotecan—ovarian cancer	0.0286	0.0515	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—ovarian cancer	0.0215	0.0387	CbGbCtD
Cyclosporine—ABCC1—Paclitaxel—ovarian cancer	0.0212	0.0381	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—ovarian cancer	0.0186	0.0335	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—ovarian cancer	0.0161	0.0289	CbGbCtD
Cyclosporine—ABCC2—Paclitaxel—ovarian cancer	0.0157	0.0282	CbGbCtD
Cyclosporine—ABCC1—Docetaxel—ovarian cancer	0.0153	0.0276	CbGbCtD
Cyclosporine—ABCC2—Carboplatin—ovarian cancer	0.0147	0.0266	CbGbCtD
Cyclosporine—ABCG2—Paclitaxel—ovarian cancer	0.0142	0.0255	CbGbCtD
Cyclosporine—ABCG2—Carboplatin—ovarian cancer	0.0133	0.024	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—ovarian cancer	0.0114	0.0205	CbGbCtD
Cyclosporine—ABCC2—Docetaxel—ovarian cancer	0.0113	0.0204	CbGbCtD
Cyclosporine—CYP3A7—Paclitaxel—ovarian cancer	0.0105	0.0188	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0105	0.0188	CbGbCtD
Cyclosporine—ABCB1—Topotecan—ovarian cancer	0.0103	0.0186	CbGbCtD
Cyclosporine—ABCG2—Docetaxel—ovarian cancer	0.0102	0.0184	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—ovarian cancer	0.00844	0.0152	CbGbCtD
Cyclosporine—CYP3A5—Paclitaxel—ovarian cancer	0.00785	0.0141	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—ovarian cancer	0.00763	0.0137	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.00756	0.0136	CbGbCtD
Cyclosporine—CYP3A7—Docetaxel—ovarian cancer	0.00756	0.0136	CbGbCtD
Cyclosporine—CYP2C8—Paclitaxel—ovarian cancer	0.00754	0.0136	CbGbCtD
Cyclosporine—ABCB1—Vinorelbine—ovarian cancer	0.00727	0.0131	CbGbCtD
Cyclosporine—CYP2D6—Vinorelbine—ovarian cancer	0.00685	0.0123	CbGbCtD
Cyclosporine—CYP3A4—Topotecan—ovarian cancer	0.00618	0.0111	CbGbCtD
Cyclosporine—CYP3A5—Docetaxel—ovarian cancer	0.00567	0.0102	CbGbCtD
Cyclosporine—CYP2C9—Paclitaxel—ovarian cancer	0.00526	0.00948	CbGbCtD
Cyclosporine—ABCB1—Paclitaxel—ovarian cancer	0.00511	0.0092	CbGbCtD
Cyclosporine—FKBP4—oviduct—ovarian cancer	0.00503	0.0491	CbGeAlD
Cyclosporine—CYP3A4—Vinorelbine—ovarian cancer	0.00435	0.00784	CbGbCtD
Cyclosporine—ABCB1—Docetaxel—ovarian cancer	0.00369	0.00665	CbGbCtD
Cyclosporine—PPIB—oviduct—ovarian cancer	0.00321	0.0314	CbGeAlD
Cyclosporine—CYP3A4—Paclitaxel—ovarian cancer	0.00306	0.00551	CbGbCtD
Cyclosporine—PPP3R2—gonad—ovarian cancer	0.00277	0.027	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—ovarian cancer	0.00275	0.00496	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—ovarian cancer	0.00259	0.00467	CbGbCtD
Cyclosporine—PPP3R2—female reproductive system—ovarian cancer	0.00247	0.0241	CbGeAlD
Cyclosporine—CYP3A4—Docetaxel—ovarian cancer	0.00221	0.00398	CbGbCtD
Cyclosporine—PPP3R2—testis—ovarian cancer	0.002	0.0195	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—ovarian cancer	0.00165	0.00297	CbGbCtD
Cyclosporine—FKBP4—embryo—ovarian cancer	0.00155	0.0151	CbGeAlD
Cyclosporine—PPID—myometrium—ovarian cancer	0.00149	0.0145	CbGeAlD
Cyclosporine—CAMLG—myometrium—ovarian cancer	0.00146	0.0143	CbGeAlD
Cyclosporine—PPIA—myometrium—ovarian cancer	0.00133	0.013	CbGeAlD
Cyclosporine—FKBP1B—female gonad—ovarian cancer	0.00129	0.0126	CbGeAlD
Cyclosporine—FKBP4—uterine cervix—ovarian cancer	0.00125	0.0122	CbGeAlD
Cyclosporine—FKBP4—decidua—ovarian cancer	0.00119	0.0116	CbGeAlD
Cyclosporine—PPID—uterine cervix—ovarian cancer	0.00116	0.0113	CbGeAlD
Cyclosporine—FKBP1B—testis—ovarian cancer	0.00115	0.0112	CbGeAlD
Cyclosporine—CAMLG—uterine cervix—ovarian cancer	0.00114	0.0111	CbGeAlD
Cyclosporine—PPID—decidua—ovarian cancer	0.0011	0.0107	CbGeAlD
Cyclosporine—CAMLG—decidua—ovarian cancer	0.00109	0.0106	CbGeAlD
Cyclosporine—PPIF—myometrium—ovarian cancer	0.00108	0.0105	CbGeAlD
Cyclosporine—FKBP4—gonad—ovarian cancer	0.00105	0.0103	CbGeAlD
Cyclosporine—PPID—endometrium—ovarian cancer	0.00105	0.0102	CbGeAlD
Cyclosporine—FKBP4—uterus—ovarian cancer	0.00104	0.0102	CbGeAlD
Cyclosporine—PPP3CA—myometrium—ovarian cancer	0.00103	0.0101	CbGeAlD
Cyclosporine—CAMLG—endometrium—ovarian cancer	0.00103	0.0101	CbGeAlD
Cyclosporine—PPIB—myometrium—ovarian cancer	0.00103	0.01	CbGeAlD
Cyclosporine—PPID—gonad—ovarian cancer	0.00097	0.00946	CbGeAlD
Cyclosporine—CAMLG—gonad—ovarian cancer	0.000956	0.00933	CbGeAlD
Cyclosporine—CAMLG—uterus—ovarian cancer	0.00095	0.00927	CbGeAlD
Cyclosporine—PPIA—endometrium—ovarian cancer	0.000939	0.00916	CbGeAlD
Cyclosporine—FKBP4—female reproductive system—ovarian cancer	0.000939	0.00916	CbGeAlD
Cyclosporine—PPID—female reproductive system—ovarian cancer	0.000866	0.00845	CbGeAlD
Cyclosporine—PPIA—uterus—ovarian cancer	0.000865	0.00844	CbGeAlD
Cyclosporine—SLC10A2—vagina—ovarian cancer	0.000857	0.00836	CbGeAlD
Cyclosporine—FKBP4—female gonad—ovarian cancer	0.000854	0.00833	CbGeAlD
Cyclosporine—CAMLG—female reproductive system—ovarian cancer	0.000854	0.00833	CbGeAlD
Cyclosporine—PPIF—uterine cervix—ovarian cancer	0.000841	0.0082	CbGeAlD
Cyclosporine—FKBP1B—lymph node—ovarian cancer	0.000831	0.0081	CbGeAlD
Cyclosporine—PPID—bone marrow—ovarian cancer	0.000818	0.00798	CbGeAlD
Cyclosporine—PPIB—epithelium—ovarian cancer	0.000807	0.00788	CbGeAlD
Cyclosporine—CAMLG—bone marrow—ovarian cancer	0.000806	0.00787	CbGeAlD
Cyclosporine—PPP3CA—uterine cervix—ovarian cancer	0.000805	0.00785	CbGeAlD
Cyclosporine—PPIF—decidua—ovarian cancer	0.000801	0.00782	CbGeAlD
Cyclosporine—PPIB—uterine cervix—ovarian cancer	0.0008	0.00781	CbGeAlD
Cyclosporine—PPID—female gonad—ovarian cancer	0.000788	0.00769	CbGeAlD
Cyclosporine—PPID—vagina—ovarian cancer	0.000784	0.00764	CbGeAlD
Cyclosporine—CAMLG—female gonad—ovarian cancer	0.000777	0.00758	CbGeAlD
Cyclosporine—CAMLG—vagina—ovarian cancer	0.000772	0.00754	CbGeAlD
Cyclosporine—PPP3CA—decidua—ovarian cancer	0.000767	0.00748	CbGeAlD
Cyclosporine—PPIB—decidua—ovarian cancer	0.000763	0.00744	CbGeAlD
Cyclosporine—PPIF—endometrium—ovarian cancer	0.00076	0.00742	CbGeAlD
Cyclosporine—FKBP4—testis—ovarian cancer	0.000758	0.00739	CbGeAlD
Cyclosporine—PPIA—bone marrow—ovarian cancer	0.000734	0.00716	CbGeAlD
Cyclosporine—PPP3CA—endometrium—ovarian cancer	0.000728	0.0071	CbGeAlD
Cyclosporine—PPIB—endometrium—ovarian cancer	0.000724	0.00706	CbGeAlD
Cyclosporine—PPIA—female gonad—ovarian cancer	0.000708	0.00691	CbGeAlD
Cyclosporine—PPIF—gonad—ovarian cancer	0.000705	0.00688	CbGeAlD
Cyclosporine—PPIA—vagina—ovarian cancer	0.000704	0.00686	CbGeAlD
Cyclosporine—PPIF—uterus—ovarian cancer	0.000701	0.00684	CbGeAlD
Cyclosporine—PPID—testis—ovarian cancer	0.000699	0.00682	CbGeAlD
Cyclosporine—CAMLG—testis—ovarian cancer	0.000689	0.00672	CbGeAlD
Cyclosporine—FKBP1A—myometrium—ovarian cancer	0.000687	0.00671	CbGeAlD
Cyclosporine—PPIB—gonad—ovarian cancer	0.000671	0.00655	CbGeAlD
Cyclosporine—PPP3CA—uterus—ovarian cancer	0.000671	0.00655	CbGeAlD
Cyclosporine—PPIB—uterus—ovarian cancer	0.000667	0.00651	CbGeAlD
Cyclosporine—PPIF—female reproductive system—ovarian cancer	0.00063	0.00615	CbGeAlD
Cyclosporine—PPIA—testis—ovarian cancer	0.000628	0.00612	CbGeAlD
Cyclosporine—PPP3CA—female reproductive system—ovarian cancer	0.000603	0.00588	CbGeAlD
Cyclosporine—PPIB—female reproductive system—ovarian cancer	0.0006	0.00585	CbGeAlD
Cyclosporine—PPIF—bone marrow—ovarian cancer	0.000595	0.0058	CbGeAlD
Cyclosporine—SLC10A1—gonad—ovarian cancer	0.000574	0.0056	CbGeAlD
Cyclosporine—PPIF—female gonad—ovarian cancer	0.000573	0.00559	CbGeAlD
Cyclosporine—PPIF—vagina—ovarian cancer	0.00057	0.00556	CbGeAlD
Cyclosporine—PPP3CA—bone marrow—ovarian cancer	0.000569	0.00556	CbGeAlD
Cyclosporine—PPIB—bone marrow—ovarian cancer	0.000566	0.00552	CbGeAlD
Cyclosporine—ABCC10—myometrium—ovarian cancer	0.000551	0.00537	CbGeAlD
Cyclosporine—FKBP4—lymph node—ovarian cancer	0.000549	0.00536	CbGeAlD
Cyclosporine—PPP3CA—female gonad—ovarian cancer	0.000549	0.00535	CbGeAlD
Cyclosporine—PPIB—female gonad—ovarian cancer	0.000546	0.00532	CbGeAlD
Cyclosporine—PPP3CA—vagina—ovarian cancer	0.000546	0.00532	CbGeAlD
Cyclosporine—PPIB—vagina—ovarian cancer	0.000542	0.00529	CbGeAlD
Cyclosporine—FKBP1A—epithelium—ovarian cancer	0.000539	0.00526	CbGeAlD
Cyclosporine—FKBP1A—uterine cervix—ovarian cancer	0.000535	0.00522	CbGeAlD
Cyclosporine—SLC10A1—female reproductive system—ovarian cancer	0.000513	0.005	CbGeAlD
Cyclosporine—FKBP1A—decidua—ovarian cancer	0.00051	0.00497	CbGeAlD
Cyclosporine—PPIF—testis—ovarian cancer	0.000508	0.00496	CbGeAlD
Cyclosporine—PPID—lymph node—ovarian cancer	0.000507	0.00494	CbGeAlD
Cyclosporine—CAMLG—lymph node—ovarian cancer	0.0005	0.00487	CbGeAlD
Cyclosporine—PPP3CA—testis—ovarian cancer	0.000487	0.00475	CbGeAlD
Cyclosporine—PPIB—testis—ovarian cancer	0.000484	0.00472	CbGeAlD
Cyclosporine—FKBP1A—endometrium—ovarian cancer	0.000484	0.00472	CbGeAlD
Cyclosporine—PPIA—lymph node—ovarian cancer	0.000455	0.00444	CbGeAlD
Cyclosporine—FKBP1A—gonad—ovarian cancer	0.000449	0.00438	CbGeAlD
Cyclosporine—FKBP1A—uterus—ovarian cancer	0.000446	0.00435	CbGeAlD
Cyclosporine—ABCC10—uterine cervix—ovarian cancer	0.000429	0.00418	CbGeAlD
Cyclosporine—SLC10A1—testis—ovarian cancer	0.000414	0.00404	CbGeAlD
Cyclosporine—ABCC3—decidua—ovarian cancer	0.00041	0.004	CbGeAlD
Cyclosporine—ABCB11—testis—ovarian cancer	0.000409	0.00399	CbGeAlD
Cyclosporine—ABCC10—decidua—ovarian cancer	0.000408	0.00398	CbGeAlD
Cyclosporine—FKBP1A—female reproductive system—ovarian cancer	0.000401	0.00391	CbGeAlD
Cyclosporine—ABCC1—myometrium—ovarian cancer	0.000389	0.0038	CbGeAlD
Cyclosporine—ABCC10—endometrium—ovarian cancer	0.000388	0.00378	CbGeAlD
Cyclosporine—FKBP1A—bone marrow—ovarian cancer	0.000378	0.00369	CbGeAlD
Cyclosporine—PPIF—lymph node—ovarian cancer	0.000369	0.0036	CbGeAlD
Cyclosporine—FKBP1A—female gonad—ovarian cancer	0.000365	0.00356	CbGeAlD
Cyclosporine—FKBP1A—vagina—ovarian cancer	0.000362	0.00354	CbGeAlD
Cyclosporine—ABCC10—gonad—ovarian cancer	0.000359	0.00351	CbGeAlD
Cyclosporine—ABCC10—uterus—ovarian cancer	0.000357	0.00348	CbGeAlD
Cyclosporine—PPP3CA—lymph node—ovarian cancer	0.000353	0.00344	CbGeAlD
Cyclosporine—PPIB—lymph node—ovarian cancer	0.000351	0.00342	CbGeAlD
Cyclosporine—SLCO1B1—female reproductive system—ovarian cancer	0.00034	0.00332	CbGeAlD
Cyclosporine—FKBP1A—testis—ovarian cancer	0.000323	0.00316	CbGeAlD
Cyclosporine—ABCC3—female reproductive system—ovarian cancer	0.000323	0.00315	CbGeAlD
Cyclosporine—ABCG2—myometrium—ovarian cancer	0.000322	0.00315	CbGeAlD
Cyclosporine—ABCC10—female reproductive system—ovarian cancer	0.000321	0.00313	CbGeAlD
Cyclosporine—ABCC10—bone marrow—ovarian cancer	0.000303	0.00296	CbGeAlD
Cyclosporine—ABCC1—uterine cervix—ovarian cancer	0.000303	0.00296	CbGeAlD
Cyclosporine—ABCC3—female gonad—ovarian cancer	0.000294	0.00286	CbGeAlD
Cyclosporine—ABCC10—female gonad—ovarian cancer	0.000292	0.00285	CbGeAlD
Cyclosporine—ABCC10—vagina—ovarian cancer	0.00029	0.00283	CbGeAlD
Cyclosporine—ABCC1—decidua—ovarian cancer	0.000289	0.00282	CbGeAlD
Cyclosporine—ABCC1—endometrium—ovarian cancer	0.000274	0.00267	CbGeAlD
Cyclosporine—ABCC3—testis—ovarian cancer	0.00026	0.00254	CbGeAlD
Cyclosporine—ABCC10—testis—ovarian cancer	0.000259	0.00253	CbGeAlD
Cyclosporine—ABCC2—female reproductive system—ovarian cancer	0.000258	0.00251	CbGeAlD
Cyclosporine—ABCC1—uterus—ovarian cancer	0.000253	0.00246	CbGeAlD
Cyclosporine—ABCG2—uterine cervix—ovarian cancer	0.000251	0.00245	CbGeAlD
Cyclosporine—ABCG2—decidua—ovarian cancer	0.000239	0.00233	CbGeAlD
Cyclosporine—FKBP1A—lymph node—ovarian cancer	0.000234	0.00229	CbGeAlD
Cyclosporine—CYP2C8—endometrium—ovarian cancer	0.000233	0.00228	CbGeAlD
Cyclosporine—CYP3A5—uterine cervix—ovarian cancer	0.000233	0.00227	CbGeAlD
Cyclosporine—ABCG2—endometrium—ovarian cancer	0.000227	0.00221	CbGeAlD
Cyclosporine—SLCO1A2—testis—ovarian cancer	0.000223	0.00218	CbGeAlD
Cyclosporine—ABCG2—uterus—ovarian cancer	0.000209	0.00204	CbGeAlD
Cyclosporine—ABCC2—testis—ovarian cancer	0.000208	0.00203	CbGeAlD
Cyclosporine—ABCC1—female gonad—ovarian cancer	0.000207	0.00202	CbGeAlD
Cyclosporine—ABCC1—vagina—ovarian cancer	0.000205	0.002	CbGeAlD
Cyclosporine—CYP2C19—vagina—ovarian cancer	0.0002	0.00195	CbGeAlD
Cyclosporine—CYP2C8—female reproductive system—ovarian cancer	0.000193	0.00189	CbGeAlD
Cyclosporine—ABCC3—lymph node—ovarian cancer	0.000189	0.00184	CbGeAlD
Cyclosporine—ABCC10—lymph node—ovarian cancer	0.000188	0.00183	CbGeAlD
Cyclosporine—ABCC1—testis—ovarian cancer	0.000183	0.00179	CbGeAlD
Cyclosporine—ABCG2—bone marrow—ovarian cancer	0.000177	0.00173	CbGeAlD
Cyclosporine—CYP2C8—vagina—ovarian cancer	0.000175	0.00171	CbGeAlD
Cyclosporine—CYP2C9—female reproductive system—ovarian cancer	0.000172	0.00168	CbGeAlD
Cyclosporine—ABCG2—female gonad—ovarian cancer	0.000171	0.00167	CbGeAlD
Cyclosporine—ABCG2—vagina—ovarian cancer	0.00017	0.00166	CbGeAlD
Cyclosporine—ABCB1—myometrium—ovarian cancer	0.000159	0.00155	CbGeAlD
Cyclosporine—CYP3A5—female gonad—ovarian cancer	0.000159	0.00155	CbGeAlD
Cyclosporine—CYP3A5—vagina—ovarian cancer	0.000158	0.00154	CbGeAlD
Cyclosporine—CYP2C8—testis—ovarian cancer	0.000156	0.00152	CbGeAlD
Cyclosporine—ABCB1—embryo—ovarian cancer	0.000153	0.00149	CbGeAlD
Cyclosporine—ABCG2—testis—ovarian cancer	0.000152	0.00148	CbGeAlD
Cyclosporine—ABCC2—lymph node—ovarian cancer	0.000151	0.00147	CbGeAlD
Cyclosporine—ABCC1—lymph node—ovarian cancer	0.000133	0.0013	CbGeAlD
Cyclosporine—CYP3A4—female reproductive system—ovarian cancer	0.000131	0.00128	CbGeAlD
Cyclosporine—CYP2D6—female reproductive system—ovarian cancer	0.000129	0.00126	CbGeAlD
Cyclosporine—ABCB1—epithelium—ovarian cancer	0.000125	0.00122	CbGeAlD
Cyclosporine—ABCB1—uterine cervix—ovarian cancer	0.000124	0.00121	CbGeAlD
Cyclosporine—ABCB1—decidua—ovarian cancer	0.000118	0.00115	CbGeAlD
Cyclosporine—CYP2D6—female gonad—ovarian cancer	0.000117	0.00114	CbGeAlD
Cyclosporine—ABCB1—endometrium—ovarian cancer	0.000112	0.00109	CbGeAlD
Cyclosporine—ABCG2—lymph node—ovarian cancer	0.00011	0.00107	CbGeAlD
Cyclosporine—CYP2D6—testis—ovarian cancer	0.000104	0.00101	CbGeAlD
Cyclosporine—ABCB1—gonad—ovarian cancer	0.000104	0.00101	CbGeAlD
Cyclosporine—ABCB1—uterus—ovarian cancer	0.000103	0.00101	CbGeAlD
Cyclosporine—ABCB1—female reproductive system—ovarian cancer	9.27e-05	0.000904	CbGeAlD
Cyclosporine—ABCB1—bone marrow—ovarian cancer	8.75e-05	0.000854	CbGeAlD
Cyclosporine—ABCB1—female gonad—ovarian cancer	8.44e-05	0.000823	CbGeAlD
Cyclosporine—ABCB1—vagina—ovarian cancer	8.38e-05	0.000818	CbGeAlD
Cyclosporine—ABCB1—testis—ovarian cancer	7.48e-05	0.00073	CbGeAlD
Cyclosporine—Pneumonia—Epirubicin—ovarian cancer	6.73e-05	0.000441	CcSEcCtD
Cyclosporine—Convulsion—Docetaxel—ovarian cancer	6.71e-05	0.00044	CcSEcCtD
Cyclosporine—Paraesthesia—Paclitaxel—ovarian cancer	6.7e-05	0.000439	CcSEcCtD
Cyclosporine—Hypertension—Docetaxel—ovarian cancer	6.69e-05	0.000439	CcSEcCtD
Cyclosporine—Infestation NOS—Epirubicin—ovarian cancer	6.69e-05	0.000438	CcSEcCtD
Cyclosporine—Infestation—Epirubicin—ovarian cancer	6.69e-05	0.000438	CcSEcCtD
Cyclosporine—Bronchitis—Doxorubicin—ovarian cancer	6.68e-05	0.000438	CcSEcCtD
Cyclosporine—Dyspnoea—Paclitaxel—ovarian cancer	6.65e-05	0.000436	CcSEcCtD
Cyclosporine—Somnolence—Paclitaxel—ovarian cancer	6.63e-05	0.000435	CcSEcCtD
Cyclosporine—Arthralgia—Docetaxel—ovarian cancer	6.6e-05	0.000433	CcSEcCtD
Cyclosporine—Myalgia—Docetaxel—ovarian cancer	6.6e-05	0.000433	CcSEcCtD
Cyclosporine—Chest pain—Docetaxel—ovarian cancer	6.6e-05	0.000433	CcSEcCtD
Cyclosporine—Nausea—Vinorelbine—ovarian cancer	6.59e-05	0.000432	CcSEcCtD
Cyclosporine—Renal failure—Epirubicin—ovarian cancer	6.58e-05	0.000431	CcSEcCtD
Cyclosporine—Dyspepsia—Paclitaxel—ovarian cancer	6.57e-05	0.000431	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Epirubicin—ovarian cancer	6.56e-05	0.00043	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	6.55e-05	0.00043	CcSEcCtD
Cyclosporine—Jaundice—Epirubicin—ovarian cancer	6.52e-05	0.000427	CcSEcCtD
Cyclosporine—Stomatitis—Epirubicin—ovarian cancer	6.52e-05	0.000427	CcSEcCtD
Cyclosporine—Urinary tract infection—Epirubicin—ovarian cancer	6.5e-05	0.000426	CcSEcCtD
Cyclosporine—Conjunctivitis—Epirubicin—ovarian cancer	6.5e-05	0.000426	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—ovarian cancer	6.49e-05	0.000425	CcSEcCtD
Cyclosporine—Decreased appetite—Paclitaxel—ovarian cancer	6.49e-05	0.000425	CcSEcCtD
Cyclosporine—Dry mouth—Docetaxel—ovarian cancer	6.45e-05	0.000423	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	6.45e-05	0.000423	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	6.44e-05	0.000422	CcSEcCtD
Cyclosporine—Fatigue—Paclitaxel—ovarian cancer	6.43e-05	0.000422	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—ovarian cancer	6.41e-05	0.00042	CcSEcCtD
Cyclosporine—Constipation—Paclitaxel—ovarian cancer	6.38e-05	0.000418	CcSEcCtD
Cyclosporine—Pain—Paclitaxel—ovarian cancer	6.38e-05	0.000418	CcSEcCtD
Cyclosporine—Haematuria—Epirubicin—ovarian cancer	6.38e-05	0.000418	CcSEcCtD
Cyclosporine—Confusional state—Docetaxel—ovarian cancer	6.38e-05	0.000418	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Epirubicin—ovarian cancer	6.33e-05	0.000415	CcSEcCtD
Cyclosporine—Anaphylactic shock—Docetaxel—ovarian cancer	6.32e-05	0.000415	CcSEcCtD
Cyclosporine—Oedema—Docetaxel—ovarian cancer	6.32e-05	0.000415	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—ovarian cancer	6.32e-05	0.000414	CcSEcCtD
Cyclosporine—Epistaxis—Epirubicin—ovarian cancer	6.31e-05	0.000414	CcSEcCtD
Cyclosporine—Infection—Docetaxel—ovarian cancer	6.28e-05	0.000412	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—ovarian cancer	6.28e-05	0.000412	CcSEcCtD
Cyclosporine—Sinusitis—Epirubicin—ovarian cancer	6.28e-05	0.000411	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—ovarian cancer	6.26e-05	0.00041	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—ovarian cancer	6.22e-05	0.000408	CcSEcCtD
Cyclosporine—Nervous system disorder—Docetaxel—ovarian cancer	6.2e-05	0.000407	CcSEcCtD
Cyclosporine—Thrombocytopenia—Docetaxel—ovarian cancer	6.19e-05	0.000406	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—ovarian cancer	6.19e-05	0.000406	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—ovarian cancer	6.19e-05	0.000406	CcSEcCtD
Cyclosporine—Feeling abnormal—Paclitaxel—ovarian cancer	6.15e-05	0.000403	CcSEcCtD
Cyclosporine—Skin disorder—Docetaxel—ovarian cancer	6.14e-05	0.000403	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Paclitaxel—ovarian cancer	6.1e-05	0.0004	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—ovarian cancer	6.08e-05	0.000399	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—ovarian cancer	6.07e-05	0.000398	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—ovarian cancer	6.04e-05	0.000396	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—ovarian cancer	6.03e-05	0.000395	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—ovarian cancer	6.03e-05	0.000395	CcSEcCtD
Cyclosporine—Anorexia—Docetaxel—ovarian cancer	6.03e-05	0.000395	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—ovarian cancer	6.02e-05	0.000395	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—ovarian cancer	6.02e-05	0.000394	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—ovarian cancer	6.02e-05	0.000394	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—ovarian cancer	6e-05	0.000394	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—ovarian cancer	6e-05	0.000394	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—ovarian cancer	5.97e-05	0.000392	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—ovarian cancer	5.96e-05	0.000391	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—ovarian cancer	5.93e-05	0.000389	CcSEcCtD
Cyclosporine—Urticaria—Paclitaxel—ovarian cancer	5.93e-05	0.000389	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—ovarian cancer	5.9e-05	0.000387	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—ovarian cancer	5.9e-05	0.000387	CcSEcCtD
Cyclosporine—Abdominal pain—Paclitaxel—ovarian cancer	5.9e-05	0.000387	CcSEcCtD
Cyclosporine—Body temperature increased—Paclitaxel—ovarian cancer	5.9e-05	0.000387	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—ovarian cancer	5.89e-05	0.000386	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—ovarian cancer	5.85e-05	0.000384	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—ovarian cancer	5.84e-05	0.000383	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—ovarian cancer	5.81e-05	0.000381	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—ovarian cancer	5.79e-05	0.000379	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	5.76e-05	0.000378	CcSEcCtD
Cyclosporine—Insomnia—Docetaxel—ovarian cancer	5.72e-05	0.000375	CcSEcCtD
Cyclosporine—Paraesthesia—Docetaxel—ovarian cancer	5.68e-05	0.000372	CcSEcCtD
Cyclosporine—Dyspnoea—Docetaxel—ovarian cancer	5.64e-05	0.00037	CcSEcCtD
Cyclosporine—Somnolence—Docetaxel—ovarian cancer	5.62e-05	0.000369	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—ovarian cancer	5.6e-05	0.000367	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—ovarian cancer	5.58e-05	0.000366	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—ovarian cancer	5.57e-05	0.000365	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—ovarian cancer	5.57e-05	0.000365	CcSEcCtD
Cyclosporine—Dyspepsia—Docetaxel—ovarian cancer	5.57e-05	0.000365	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—ovarian cancer	5.56e-05	0.000364	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—ovarian cancer	5.56e-05	0.000364	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—ovarian cancer	5.53e-05	0.000362	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—ovarian cancer	5.51e-05	0.000361	CcSEcCtD
Cyclosporine—Decreased appetite—Docetaxel—ovarian cancer	5.5e-05	0.00036	CcSEcCtD
Cyclosporine—Hypersensitivity—Paclitaxel—ovarian cancer	5.5e-05	0.00036	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—ovarian cancer	5.49e-05	0.00036	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Docetaxel—ovarian cancer	5.46e-05	0.000358	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—ovarian cancer	5.46e-05	0.000358	CcSEcCtD
Cyclosporine—Fatigue—Docetaxel—ovarian cancer	5.45e-05	0.000357	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—ovarian cancer	5.45e-05	0.000357	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—ovarian cancer	5.45e-05	0.000357	CcSEcCtD
Cyclosporine—ABCB1—lymph node—ovarian cancer	5.42e-05	0.000529	CbGeAlD
Cyclosporine—Mediastinal disorder—Epirubicin—ovarian cancer	5.41e-05	0.000355	CcSEcCtD
Cyclosporine—Constipation—Docetaxel—ovarian cancer	5.41e-05	0.000355	CcSEcCtD
Cyclosporine—Pain—Docetaxel—ovarian cancer	5.41e-05	0.000355	CcSEcCtD
Cyclosporine—Chills—Epirubicin—ovarian cancer	5.39e-05	0.000353	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—ovarian cancer	5.36e-05	0.000352	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—ovarian cancer	5.35e-05	0.000351	CcSEcCtD
Cyclosporine—Asthenia—Paclitaxel—ovarian cancer	5.35e-05	0.000351	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—ovarian cancer	5.31e-05	0.000348	CcSEcCtD
Cyclosporine—Pruritus—Paclitaxel—ovarian cancer	5.28e-05	0.000346	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—ovarian cancer	5.26e-05	0.000345	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—ovarian cancer	5.23e-05	0.000343	CcSEcCtD
Cyclosporine—Feeling abnormal—Docetaxel—ovarian cancer	5.21e-05	0.000342	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—ovarian cancer	5.18e-05	0.00034	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Docetaxel—ovarian cancer	5.17e-05	0.000339	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—ovarian cancer	5.16e-05	0.000338	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—ovarian cancer	5.15e-05	0.000338	CcSEcCtD
Cyclosporine—Tension—Epirubicin—ovarian cancer	5.13e-05	0.000336	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—ovarian cancer	5.12e-05	0.000336	CcSEcCtD
Cyclosporine—Diarrhoea—Paclitaxel—ovarian cancer	5.11e-05	0.000335	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—ovarian cancer	5.08e-05	0.000333	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—ovarian cancer	5.04e-05	0.00033	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—ovarian cancer	5.03e-05	0.000329	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—ovarian cancer	5.01e-05	0.000328	CcSEcCtD
Cyclosporine—Abdominal pain—Docetaxel—ovarian cancer	5e-05	0.000328	CcSEcCtD
Cyclosporine—Body temperature increased—Docetaxel—ovarian cancer	5e-05	0.000328	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—ovarian cancer	4.99e-05	0.000327	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—ovarian cancer	4.96e-05	0.000325	CcSEcCtD
Cyclosporine—Dizziness—Paclitaxel—ovarian cancer	4.93e-05	0.000323	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—ovarian cancer	4.93e-05	0.000323	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—ovarian cancer	4.91e-05	0.000322	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—ovarian cancer	4.87e-05	0.000319	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—ovarian cancer	4.85e-05	0.000318	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—ovarian cancer	4.84e-05	0.000317	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—ovarian cancer	4.83e-05	0.000317	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—ovarian cancer	4.8e-05	0.000315	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—ovarian cancer	4.77e-05	0.000312	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—ovarian cancer	4.75e-05	0.000311	CcSEcCtD
Cyclosporine—Vomiting—Paclitaxel—ovarian cancer	4.74e-05	0.000311	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—ovarian cancer	4.74e-05	0.00031	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—ovarian cancer	4.71e-05	0.000309	CcSEcCtD
Cyclosporine—Rash—Paclitaxel—ovarian cancer	4.7e-05	0.000308	CcSEcCtD
Cyclosporine—Dermatitis—Paclitaxel—ovarian cancer	4.7e-05	0.000308	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—ovarian cancer	4.7e-05	0.000308	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—ovarian cancer	4.7e-05	0.000308	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—ovarian cancer	4.68e-05	0.000307	CcSEcCtD
Cyclosporine—Headache—Paclitaxel—ovarian cancer	4.67e-05	0.000306	CcSEcCtD
Cyclosporine—Hypersensitivity—Docetaxel—ovarian cancer	4.66e-05	0.000305	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—ovarian cancer	4.65e-05	0.000305	CcSEcCtD
Cyclosporine—Cough—Epirubicin—ovarian cancer	4.56e-05	0.000299	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—ovarian cancer	4.56e-05	0.000299	CcSEcCtD
Cyclosporine—Asthenia—Docetaxel—ovarian cancer	4.54e-05	0.000297	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—ovarian cancer	4.53e-05	0.000297	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—ovarian cancer	4.51e-05	0.000296	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—ovarian cancer	4.49e-05	0.000294	CcSEcCtD
Cyclosporine—Pruritus—Docetaxel—ovarian cancer	4.47e-05	0.000293	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—ovarian cancer	4.47e-05	0.000293	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—ovarian cancer	4.45e-05	0.000292	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—ovarian cancer	4.45e-05	0.000292	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—ovarian cancer	4.45e-05	0.000292	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—ovarian cancer	4.44e-05	0.000291	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—ovarian cancer	4.43e-05	0.000291	CcSEcCtD
Cyclosporine—Nausea—Paclitaxel—ovarian cancer	4.43e-05	0.000291	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	4.42e-05	0.00029	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—ovarian cancer	4.4e-05	0.000288	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—ovarian cancer	4.36e-05	0.000286	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—ovarian cancer	4.35e-05	0.000285	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—ovarian cancer	4.35e-05	0.000285	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—ovarian cancer	4.33e-05	0.000284	CcSEcCtD
Cyclosporine—Diarrhoea—Docetaxel—ovarian cancer	4.33e-05	0.000284	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—ovarian cancer	4.3e-05	0.000282	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—ovarian cancer	4.27e-05	0.00028	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—ovarian cancer	4.27e-05	0.00028	CcSEcCtD
Cyclosporine—Infection—Epirubicin—ovarian cancer	4.24e-05	0.000278	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—ovarian cancer	4.22e-05	0.000277	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—ovarian cancer	4.19e-05	0.000275	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—ovarian cancer	4.18e-05	0.000274	CcSEcCtD
Cyclosporine—Dizziness—Docetaxel—ovarian cancer	4.18e-05	0.000274	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—ovarian cancer	4.18e-05	0.000274	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—ovarian cancer	4.18e-05	0.000274	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—ovarian cancer	4.14e-05	0.000272	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—ovarian cancer	4.12e-05	0.00027	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—ovarian cancer	4.12e-05	0.00027	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—ovarian cancer	4.12e-05	0.00027	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—ovarian cancer	4.12e-05	0.00027	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—ovarian cancer	4.1e-05	0.000269	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	4.09e-05	0.000268	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—ovarian cancer	4.07e-05	0.000267	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—ovarian cancer	4.07e-05	0.000267	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—ovarian cancer	4.03e-05	0.000264	CcSEcCtD
Cyclosporine—Vomiting—Docetaxel—ovarian cancer	4.02e-05	0.000264	CcSEcCtD
Cyclosporine—Rash—Docetaxel—ovarian cancer	3.99e-05	0.000261	CcSEcCtD
Cyclosporine—Dermatitis—Docetaxel—ovarian cancer	3.98e-05	0.000261	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—ovarian cancer	3.98e-05	0.000261	CcSEcCtD
Cyclosporine—Headache—Docetaxel—ovarian cancer	3.96e-05	0.00026	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—ovarian cancer	3.95e-05	0.000259	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—ovarian cancer	3.95e-05	0.000259	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—ovarian cancer	3.92e-05	0.000257	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	3.89e-05	0.000255	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—ovarian cancer	3.87e-05	0.000254	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—ovarian cancer	3.86e-05	0.000253	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—ovarian cancer	3.86e-05	0.000253	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—ovarian cancer	3.83e-05	0.000251	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—ovarian cancer	3.83e-05	0.000251	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—ovarian cancer	3.82e-05	0.00025	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—ovarian cancer	3.8e-05	0.000249	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—ovarian cancer	3.79e-05	0.000249	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—ovarian cancer	3.76e-05	0.000247	CcSEcCtD
Cyclosporine—Nausea—Docetaxel—ovarian cancer	3.76e-05	0.000246	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—ovarian cancer	3.76e-05	0.000246	CcSEcCtD
Cyclosporine—Decreased appetite—Epirubicin—ovarian cancer	3.71e-05	0.000243	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—ovarian cancer	3.68e-05	0.000241	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—ovarian cancer	3.68e-05	0.000241	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—ovarian cancer	3.65e-05	0.000239	CcSEcCtD
Cyclosporine—Pain—Epirubicin—ovarian cancer	3.65e-05	0.000239	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.6e-05	0.000236	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—ovarian cancer	3.57e-05	0.000234	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—ovarian cancer	3.54e-05	0.000232	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—ovarian cancer	3.52e-05	0.000231	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—ovarian cancer	3.52e-05	0.00023	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—ovarian cancer	3.51e-05	0.00023	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—ovarian cancer	3.49e-05	0.000229	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—ovarian cancer	3.47e-05	0.000228	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—ovarian cancer	3.43e-05	0.000225	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.41e-05	0.000223	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—ovarian cancer	3.4e-05	0.000223	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—ovarian cancer	3.39e-05	0.000222	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—ovarian cancer	3.38e-05	0.000221	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—ovarian cancer	3.38e-05	0.000221	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—ovarian cancer	3.37e-05	0.000221	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—ovarian cancer	3.37e-05	0.000221	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—ovarian cancer	3.25e-05	0.000213	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.23e-05	0.000212	CcSEcCtD
Cyclosporine—Hypersensitivity—Epirubicin—ovarian cancer	3.14e-05	0.000206	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—ovarian cancer	3.14e-05	0.000206	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—ovarian cancer	3.12e-05	0.000205	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—ovarian cancer	3.12e-05	0.000205	CcSEcCtD
Cyclosporine—Asthenia—Epirubicin—ovarian cancer	3.06e-05	0.000201	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—ovarian cancer	3.02e-05	0.000198	CcSEcCtD
Cyclosporine—Diarrhoea—Epirubicin—ovarian cancer	2.92e-05	0.000191	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—ovarian cancer	2.91e-05	0.000191	CcSEcCtD
Cyclosporine—Asthenia—Doxorubicin—ovarian cancer	2.83e-05	0.000186	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—ovarian cancer	2.82e-05	0.000185	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—ovarian cancer	2.79e-05	0.000183	CcSEcCtD
Cyclosporine—Vomiting—Epirubicin—ovarian cancer	2.71e-05	0.000178	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—ovarian cancer	2.7e-05	0.000177	CcSEcCtD
Cyclosporine—Rash—Epirubicin—ovarian cancer	2.69e-05	0.000176	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—ovarian cancer	2.69e-05	0.000176	CcSEcCtD
Cyclosporine—Headache—Epirubicin—ovarian cancer	2.67e-05	0.000175	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—ovarian cancer	2.61e-05	0.000171	CcSEcCtD
Cyclosporine—Nausea—Epirubicin—ovarian cancer	2.53e-05	0.000166	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—ovarian cancer	2.51e-05	0.000165	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—ovarian cancer	2.49e-05	0.000163	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—ovarian cancer	2.49e-05	0.000163	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—ovarian cancer	2.47e-05	0.000162	CcSEcCtD
Cyclosporine—Nausea—Doxorubicin—ovarian cancer	2.34e-05	0.000154	CcSEcCtD
Cyclosporine—SLCO1B1—Metabolism—TYMS—ovarian cancer	6.83e-06	7.51e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MYC—ovarian cancer	6.81e-06	7.49e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CG—ovarian cancer	6.73e-06	7.4e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ERBB2—ovarian cancer	6.73e-06	7.4e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—VEGFA—ovarian cancer	6.68e-06	7.35e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MAPK1—ovarian cancer	6.66e-06	7.33e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—EGFR—ovarian cancer	6.66e-06	7.33e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MTOR—ovarian cancer	6.64e-06	7.3e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CB—ovarian cancer	6.64e-06	7.3e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—STAT3—ovarian cancer	6.62e-06	7.28e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NRAS—ovarian cancer	6.6e-06	7.26e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—IL6—ovarian cancer	6.6e-06	7.26e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—AKT1—ovarian cancer	6.59e-06	7.26e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6ST—ovarian cancer	6.55e-06	7.21e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—YAP1—ovarian cancer	6.53e-06	7.19e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.47e-06	7.11e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ABCB1—ovarian cancer	6.44e-06	7.08e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—CAV1—ovarian cancer	6.43e-06	7.08e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ABCB1—ovarian cancer	6.38e-06	7.02e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL8—ovarian cancer	6.38e-06	7.02e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.34e-06	6.97e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—TYMS—ovarian cancer	6.32e-06	6.96e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MAPK3—ovarian cancer	6.32e-06	6.96e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	6.3e-06	6.93e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—APC—ovarian cancer	6.3e-06	6.93e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—ovarian cancer	6.29e-06	6.92e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—TYMS—ovarian cancer	6.27e-06	6.89e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CDKN1B—ovarian cancer	6.23e-06	6.85e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CD—ovarian cancer	6.17e-06	6.79e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—FASN—ovarian cancer	6.15e-06	6.77e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—ovarian cancer	6.15e-06	6.76e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.15e-06	6.76e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CASP3—ovarian cancer	6.11e-06	6.72e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—ovarian cancer	6.1e-06	6.71e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	6.1e-06	6.71e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—AKT1—ovarian cancer	6.09e-06	6.7e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—SLC5A5—ovarian cancer	6.05e-06	6.66e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MAPK1—ovarian cancer	6.01e-06	6.62e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EGFR—ovarian cancer	6.01e-06	6.62e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYTB—ovarian cancer	5.98e-06	6.58e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCND1—ovarian cancer	5.94e-06	6.54e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CD—ovarian cancer	5.92e-06	6.51e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CTNNB1—ovarian cancer	5.89e-06	6.48e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CG—ovarian cancer	5.86e-06	6.45e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—SLC2A1—ovarian cancer	5.84e-06	6.43e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—YAP1—ovarian cancer	5.83e-06	6.42e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—CAV1—ovarian cancer	5.79e-06	6.37e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PIK3CA—ovarian cancer	5.78e-06	6.36e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.78e-06	6.36e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.77e-06	6.35e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MMP9—ovarian cancer	5.77e-06	6.35e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTEN—ovarian cancer	5.74e-06	6.31e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—YAP1—ovarian cancer	5.69e-06	6.26e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.68e-06	6.25e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—ovarian cancer	5.68e-06	6.25e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP1B1—ovarian cancer	5.6e-06	6.16e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PIK3CA—ovarian cancer	5.56e-06	6.12e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CD—ovarian cancer	5.54e-06	6.09e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.53e-06	6.09e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CAV1—ovarian cancer	5.5e-06	6.05e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CB—ovarian cancer	5.38e-06	5.92e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—YAP1—ovarian cancer	5.36e-06	5.9e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—ovarian cancer	5.35e-06	5.88e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—FASN—ovarian cancer	5.33e-06	5.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—YAP1—ovarian cancer	5.32e-06	5.85e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CG—ovarian cancer	5.27e-06	5.8e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.26e-06	5.79e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.26e-06	5.78e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	5.24e-06	5.76e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.23e-06	5.75e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.23e-06	5.75e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—ovarian cancer	5.22e-06	5.74e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—ovarian cancer	5.18e-06	5.7e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CB—ovarian cancer	5.16e-06	5.67e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CD—ovarian cancer	5.15e-06	5.67e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	5.15e-06	5.66e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—STAT3—ovarian cancer	5.13e-06	5.64e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NRAS—ovarian cancer	5.12e-06	5.63e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—IL6—ovarian cancer	5.12e-06	5.63e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CAV1—ovarian cancer	5.09e-06	5.61e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.07e-06	5.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.06e-06	5.57e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CAV1—ovarian cancer	5.05e-06	5.56e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—ovarian cancer	5.05e-06	5.56e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	5.01e-06	5.51e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	4.97e-06	5.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.95e-06	5.45e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK3—ovarian cancer	4.9e-06	5.39e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERBB2—ovarian cancer	4.89e-06	5.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	4.85e-06	5.34e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—ovarian cancer	4.83e-06	5.31e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CB—ovarian cancer	4.82e-06	5.31e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MTOR—ovarian cancer	4.82e-06	5.31e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—ovarian cancer	4.77e-06	5.25e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—FASN—ovarian cancer	4.75e-06	5.23e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—AKT1—ovarian cancer	4.72e-06	5.19e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	4.68e-06	5.15e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK1—ovarian cancer	4.66e-06	5.13e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—ovarian cancer	4.66e-06	5.13e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTEN—ovarian cancer	4.65e-06	5.11e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—FASN—ovarian cancer	4.64e-06	5.11e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CG—ovarian cancer	4.64e-06	5.11e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CD—ovarian cancer	4.64e-06	5.1e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.63e-06	5.09e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL6—ovarian cancer	4.62e-06	5.09e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ABCB1—ovarian cancer	4.61e-06	5.07e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CG—ovarian cancer	4.6e-06	5.06e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SLC5A5—ovarian cancer	4.56e-06	5.02e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—AKT1—ovarian cancer	4.54e-06	5e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—TYMS—ovarian cancer	4.53e-06	4.98e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1B—ovarian cancer	4.53e-06	4.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	4.52e-06	4.97e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CB—ovarian cancer	4.49e-06	4.94e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTEN—ovarian cancer	4.46e-06	4.9e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.42e-06	4.87e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SLC2A1—ovarian cancer	4.41e-06	4.85e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	4.41e-06	4.85e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—ovarian cancer	4.4e-06	4.85e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—FASN—ovarian cancer	4.37e-06	4.81e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—FASN—ovarian cancer	4.33e-06	4.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.33e-06	4.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	4.3e-06	4.73e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	4.3e-06	4.73e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.28e-06	4.71e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CTNNB1—ovarian cancer	4.28e-06	4.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.26e-06	4.69e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—AKT1—ovarian cancer	4.26e-06	4.69e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.23e-06	4.65e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTEN—ovarian cancer	4.17e-06	4.59e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.15e-06	4.57e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.12e-06	4.53e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CD—ovarian cancer	4.08e-06	4.49e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—ovarian cancer	4.05e-06	4.45e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CD—ovarian cancer	4.04e-06	4.45e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CB—ovarian cancer	4.04e-06	4.45e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.03e-06	4.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ABCB1—ovarian cancer	3.99e-06	4.4e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	3.98e-06	4.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	3.95e-06	4.34e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—TYMS—ovarian cancer	3.92e-06	4.32e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—ovarian cancer	3.91e-06	4.31e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—ovarian cancer	3.88e-06	4.27e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.84e-06	4.23e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	3.84e-06	4.23e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.82e-06	4.2e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	3.75e-06	4.12e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—ovarian cancer	3.74e-06	4.12e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—STAT3—ovarian cancer	3.73e-06	4.1e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—ovarian cancer	3.72e-06	4.09e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CAV1—ovarian cancer	3.65e-06	4.02e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—ovarian cancer	3.58e-06	3.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ABCB1—ovarian cancer	3.57e-06	3.92e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK3—ovarian cancer	3.56e-06	3.92e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CB—ovarian cancer	3.56e-06	3.91e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	3.53e-06	3.89e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CB—ovarian cancer	3.52e-06	3.88e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—YAP1—ovarian cancer	3.51e-06	3.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—TYMS—ovarian cancer	3.5e-06	3.85e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.5e-06	3.85e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—ovarian cancer	3.49e-06	3.84e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.48e-06	3.83e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—ovarian cancer	3.46e-06	3.81e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—TYMS—ovarian cancer	3.42e-06	3.76e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK1—ovarian cancer	3.39e-06	3.73e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—ovarian cancer	3.39e-06	3.73e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CG—ovarian cancer	3.32e-06	3.66e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—ovarian cancer	3.32e-06	3.65e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—AKT1—ovarian cancer	3.31e-06	3.64e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.28e-06	3.61e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—ovarian cancer	3.28e-06	3.61e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.25e-06	3.58e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TYMS—ovarian cancer	3.22e-06	3.54e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—ovarian cancer	3.2e-06	3.52e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TYMS—ovarian cancer	3.19e-06	3.51e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CAV1—ovarian cancer	3.16e-06	3.48e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—ovarian cancer	3.14e-06	3.46e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—ovarian cancer	3.07e-06	3.38e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—ovarian cancer	3.05e-06	3.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.02e-06	3.32e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—ovarian cancer	2.94e-06	3.24e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	2.92e-06	3.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	2.88e-06	3.17e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—FASN—ovarian cancer	2.86e-06	3.15e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CAV1—ovarian cancer	2.82e-06	3.1e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.81e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CAV1—ovarian cancer	2.75e-06	3.03e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—ovarian cancer	2.74e-06	3.01e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—ovarian cancer	2.72e-06	2.99e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.72e-06	2.99e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.7e-06	2.97e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—AKT1—ovarian cancer	2.68e-06	2.95e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—ovarian cancer	2.6e-06	2.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.6e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CAV1—ovarian cancer	2.6e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CAV1—ovarian cancer	2.57e-06	2.83e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.57e-06	2.83e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—AKT1—ovarian cancer	2.57e-06	2.83e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	2.55e-06	2.8e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.53e-06	2.79e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.51e-06	2.76e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—ovarian cancer	2.46e-06	2.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.46e-06	2.7e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—AKT1—ovarian cancer	2.4e-06	2.64e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.36e-06	2.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.34e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	2.34e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.31e-06	2.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.26e-06	2.49e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—AKT1—ovarian cancer	2.24e-06	2.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.21e-06	2.43e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.21e-06	2.43e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—ovarian cancer	2.2e-06	2.42e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—ovarian cancer	2.17e-06	2.38e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.15e-06	2.36e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.14e-06	2.36e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.11e-06	2.32e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.08e-06	2.29e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.06e-06	2.27e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—AKT1—ovarian cancer	2.01e-06	2.21e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.97e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.92e-06	2.12e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—AKT1—ovarian cancer	1.91e-06	2.1e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—ovarian cancer	1.91e-06	2.1e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.81e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.8e-06	1.98e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—AKT1—ovarian cancer	1.77e-06	1.95e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—AKT1—ovarian cancer	1.75e-06	1.93e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—ovarian cancer	1.7e-06	1.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CAV1—ovarian cancer	1.7e-06	1.87e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—ovarian cancer	1.66e-06	1.83e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—ovarian cancer	1.57e-06	1.72e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.55e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—ovarian cancer	1.55e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.55e-06	1.7e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.36e-06	1.5e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.35e-06	1.48e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—AKT1—ovarian cancer	1.27e-06	1.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.2e-06	1.32e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.18e-06	1.3e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.17e-06	1.29e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.1e-06	1.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—AKT1—ovarian cancer	1.1e-06	1.21e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.09e-06	1.2e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.02e-06	1.13e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—AKT1—ovarian cancer	9.81e-07	1.08e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—AKT1—ovarian cancer	9.57e-07	1.05e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—AKT1—ovarian cancer	9.02e-07	9.93e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—AKT1—ovarian cancer	8.94e-07	9.84e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.22e-07	7.94e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—AKT1—ovarian cancer	5.9e-07	6.49e-06	CbGpPWpGaD
